Martin Capital Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-183,986
Closed -$2.18M 75
2022
Q3
$2.18M Buy
183,986
+10,969
+6% +$166K 1.01% 41
2022
Q2
$2.64M Buy
173,017
+156,363
+939% +$2.81M 1.25% 40
2022
Q1
$352K Buy
16,654
+197
+1% +$4.25K 0.16% 62
2021
Q4
$389K Buy
16,457
+84
+0.5% +$1.8K 0.18% 59
2021
Q3
$329K Buy
16,373
+295
+2% +$6.04K 0.17% 62
2021
Q2
$323K Buy
16,078
+599
+4% +$12.8K 0.16% 60
2021
Q1
$329K Buy
15,479
+310
+2% +$6.67K 0.17% 59
2020
Q4
$331K Buy
15,169
+65
+0.4% +$1.27K 0.19% 57
2020
Q3
$266K Sell
15,104
-602
-4% -$11.2K 0.18% 55
2020
Q2
$295K Buy
15,706
+3,293
+27% +$58.3K 0.21% 49
2020
Q1
$215K Sell
12,413
-257
-2% -$5.37K 0.16% 54
2019
Q4
$267K Buy
+12,670
New +$256K 0.16% 54
2019
Q2
Sell
-8,787
Closed -$163K 59
2019
Q1
$163K Buy
+8,787
New +$157K 0.13% 56

Other funds holding MPT

Martin Capital Partners's MPT Position: Q4 2022 in Review

Martin Capital Partners sold out of Medical Properties Trust (MPT) in Q4 2022, closing a stake of 183,986 shares — an estimated $2.18M sold.

Martin Capital Partners first reported a position in MPT in Q1 2019 and held it in 13 quarters. The position peaked at $2.64M in Q2 2022. 639 funds tracked by Wall St. Rank hold MPT as of Q4 2022.

  • Martin Capital Partners reported no remaining Medical Properties Trust position as of Q4 2022 after selling out during the quarter.
  • Martin Capital Partners sold 183,986 Medical Properties Trust shares in Q4 2022, an estimated $2.18M.
  • Martin Capital Partners first reported a position in Medical Properties Trust in Q1 2019 and held it in 13 quarters.
  • Martin Capital Partners's Medical Properties Trust position peaked at $2.64M in Q2 2022.
  • 639 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2022.

Based on Martin Capital Partners's 13F filing for Q4 2022, filed 5 Jan 2023.